
NASDAQHealthcareMedical - Care Facilities
最新数据
US$37.55
+US$1.68 · +4.68%
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
前收盘价
US$37.55
+US$1.68 · +4.68%
盘中时间采用ET。市场数据可能有所延迟。
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
日内区间
当前US$37.55
52周区间
当前US$37.55
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
买入
估值
87
深度低估
情绪
56
多空交织
风险
33
中等风险
动量
71
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
日内区间
当前US$37.55
52周区间
当前US$37.55
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 31.82亿 USD | 20.35亿 USD | 13.87亿 USD | 11.44亿 USD | 7.74亿 USD |
| 销货成本 | 28.86亿 USD | 17.63亿 USD | 11.72亿 USD | 9.45亿 USD | 5.96亿 USD |
| 毛利 | 2.96亿 USD | 2.71亿 USD | 2.15亿 USD | 1.99亿 USD | 1.78亿 USD |
| 销售、一般及管理费用 | 2.17亿 USD | 1.54亿 USD | 1.13亿 USD | 7767万 USD | 6207.7万 USD |
| 营业费用 | 2.17亿 USD | 1.82亿 USD | 1.3亿 USD | 9521.3万 USD | 7959.4万 USD |
| 利息收入 | 1215.7万 USD | 1450.8万 USD | 1420.8万 USD | 197.6万 USD | 157.1万 USD |
| 利息支出 | 4992.8万 USD | 3309.7万 USD | 1610.2万 USD | 792万 USD | 539.4万 USD |
| 折旧和摊销 | 4574.9万 USD | 2792.7万 USD | 1774.8万 USD | 1754.3万 USD | 1751.7万 USD |
| 营业利润 | 7852.5万 USD | 8935万 USD | 8461.3万 USD | 1.04亿 USD | 9817.9万 USD |
| 净利润 | 2248.7万 USD | 4314.9万 USD | 6071.7万 USD | 4517.1万 USD | 6892.3万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
报告持有此股票敞口的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR8993.94万0.09%1031.91亿 USD0.06%US$137.55+0.17%
Vanguard Morningstar Total Stock Market ETFVTI5399.62万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM4294.61万0.05%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB3904万0.02%1853亿 USD0.03%US$289.48+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK2237.91万0.05%447亿 USD0.05%US$344.74+1.22%
Vanguard Extended Market ETFVXF1876.09万0.02%954亿 USD0.05%US$235+0.80%
iShares Russell 2000 Growth ETFIWO1511.52万0.11%139.17亿 USD0.24%US$356.78+0.94%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1389.64万0.09%158.4亿 USD0.03%US$53.45+0.17%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Growth ETFVBK
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。